Company determined that its usage pattern for certain assets had changed significantly and revised the useful lives of certain equipment starting in 2009.
This adjustment was considered to be a change in an accounting estimate.
The impact to the Company in 2010 and 2009 were as follows (unaudited):
## Table 0 ##
Revenue Recognition The Company recognizes revenue when title and risk of loss pass to the customer, which is usually upon shipment of product.
Although the Company may enter into long-term supply agreements with its major customers, each shipment of goods is treated as a separate sale and the prices are not fixed over the life of the agreements.
Impairment of Long-Lived Assets In accordance with ASC Topic 360, the Company periodically reviews the carrying value of its long-lived assets, whether held for use or disposal, including other intangible assets, when events and circumstances warrant such a review.
Such events and circumstances include, but are not limited to, a significant decrease in market volumes, or project life, or a loss of a major customer application (i. e. , a “triggering event”).
The Company’s impairment review is performed at each manufacturing, assembly, and technical site using data that is the basis for the Company’s annual budget (or forecast on an interim basis) and long-range plan (“LRP”).
The annual budget and LRP include a five year projection of future cash flows based on actual new products and customer commitments.
If a triggering event has occurred, the assets are identified by the operating location and management as potentially impaired and a recoverability review is performed by management.
The review will determine if a current or future alternative use exists for additional customer applications or if redeployment of the assets to any of the Company’s other operating sites around the world is justified.
The recoverability test compares projected undiscounted future cash flows to the carrying value of a product line or a specific customer application or asset grouping, as applicable.
If the undiscounted cash flow test for recoverability identifies a possible impairment, management will perform a fair value analysis.
Management determines fair value under ASC Topic 820 using the appropriate valuation technique of market, income or cost approach.
Management believes that the estimates and assumptions are reasonable however, changes in assumptions with respect to future volumes, program project life or future asset use, in addition to future cash flows underlying these estimates could affect the Company’s fair value evaluations.
Due to the sudden decline in the global automotive markets in 2008 and 2009, the Company reviewed the carrying value of its long-lived assets.
As a result of these reviews, the Company recognized $36.3 million and $72.9 million in impairment of long-lived assets (i. e. , plant and equipment) as part of restructuring
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued) NOTE 4 INCOME TAXES Earnings before income taxes and the provision for income taxes are presented in the following table.
## Table 1 ##
The provision for income taxes resulted in an effective tax rate for 2010 of 17.1% compared with rates of (103.4)% in 2009 and 237.9% in 2008.
In the first quarter of 2010, the Patient Protection and Affordable Care Act (PPACA) was signed into law.
In addition, the Health Care and Education Reconciliation Act of 2010 (“the Reconciliation Act”) was also passed, amending certain portions of the PPACA.
The PPACA contains a provision eliminating tax deductibility of retiree health care costs to the extent of federal subsidies received by plan sponsors who provide retiree prescription drug benefits equivalent to Medicare Part D coverage.
However, based upon the changes made in the Reconciliation Act, the tax benefit related to the Medicare Part D subsidies will be extended until December 31, 2012.
For all tax years ending after December 31, 2012 there will no longer be a tax benefit for the Medicare Part D subsidies.
Therefore, the impact to the Company for the loss of this future tax benefit (after December 31, 2012) was an additional tax expense of approximately $2.9 million in 2010.
The provision for income taxes for the year ended December 31, 2010 included a favorable impact of $21.2 million from the reversal of the Company’s valuation allowance on U. S.  based foreign tax credit carryforwards.
The improving financial performance of the Company’s U. S.  operations has resulted in greater certainty that the Company will be able to fully utilize existing foreign tax credit carryforwards.
The Company’s annual effective tax rate for 2010 is 17.1% which includes the impact of the reversal of the Company’s valuation allowance on U. S.  based foreign tax credit carryforwards, the change in tax legislation related to Medicare Part D subsidies, the additional tax expense associated with the BERU-Eichenauer equity investment gain and the tax benefit associated with the Company’s environmental litigation settlement.
This rate differs from the U. S.  statutory rate primarily due to foreign rates, which differ from those in the U. S. , the realization of certain business tax credits including foreign tax credits and favorable permanent differences between book and tax treatment for items, including equity in affiliates’ earnings.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued) the Company’s December 31, 2010 Consolidated Balance Sheet.
See Note 1 in the Consolidated Financial Statements for more information regarding the Company’s first quarter 2010 adoption of ASC Topic 860.
(b) In 2006, the Company entered into several interest rate swaps that had the effect of converting $325.0 million of fixed rate notes to variable rates.
In the first quarter of 2009, $100 million in interest rate swaps related to the Company’s 2009 fixed rate debt matured, and the Company terminated $150 million in interest rate swap agreements related to the Company’s 2016 fixed rate debt and $75 million of interest rate swap agreements related to the Company’s 2019 fixed rate debt.
As a result of the first quarter 2009 swap terminations, a $34.5 million gain remained in debt and is being amortized over the remaining lives of the respective 2016 and 2019 debt.
As of December 31, 2010 and 2009, the unamortized portion was $27.8 million and $31.4 million, respectively.
Annual principal payments required as of December 31, 2010 are as follows (in millions of dollars)
## Table 2 ##
The Company’s long-term debt includes various financial covenants, none of which are expected to restrict future operations.
On March 31, 2010, the Company replaced its $250 million multi-currency revolving credit facility with a new $550 million multi-currency revolving credit facility, which includes a feature that allows the Company to increase its borrowings to $600 million.
The new facility provides for borrowings through March 31, 2013, and is guaranteed by the Company’s domestic subsidiaries.
The Company has three key financial covenants as part of the credit agreement.
These covenants are a net worth test, a debt compared to EBITDA (“Earnings Before Interest, Taxes, Depreciation and Amortization”) test, and an interest coverage test.
The Company was in compliance with all covenants at December 31, 2010 and expects to remain compliant in future periods.
At December 31, 2010 and December 31, 2009 there were no outstanding borrowings under these facilities.
On September 16, 2010, the Company issued $250 million in 4.625% senior notes due 2020.
Interest is payable semi-annually on March 15 and September 15 of each year, beginning on March 15, 2011.
The senior notes were issued under the Company’s $750 million universal shelf registration filed with the Securities and Exchange Commission, leaving approximately $126 million available as of December 31, 2010.
On April 9, 2009, the Company issued $373.8 million in convertible senior notes due April 15, 2012.
Under ASC Topic 470, “Accounting for Convertible Debt Instruments That May be Settled in Cash Upon Conversion (Including Partial Cash Settlement)”, the Company must account for the convertible senior notes by bifurcating the instruments between their liability and equity components.
The value of the debt component is based on the fair value of issuing a similar nonconvertible debt security.
The equity component of the convertible debt security is calculated by deducting the value of the liability from the proceeds received at issuance.
The Company’s December 31, 2010 Consolidated Balance Sheet includes debt of $348.5 million and capital in excess of par of $36.5 million.
Additionally, ASC Topic 470 requires the Company to accrete the
addition, we are exposed to gains and losses resulting from fluctuations in foreign currency exchange rates on transactions generated by our international subsidiaries in currencies other than their local currencies.
These gains and losses are primarily driven by inter-company transactions.
These exposures are included in other income (expense), net on the consolidated statements of income.
Since 2007, we have used foreign currency forward contracts to reduce the risk from exchange rate fluctuations on inter-company transactions and projected inventory purchases for our Canadian subsidiary.
Beginning in December 2008, we began using foreign currency forward contracts in order to reduce the risk associated with foreign currency exchange rate fluctuations on inter-company transactions for our European subsidiary.
We do not enter into derivative financial instruments for speculative or trading purposes.
Based on the foreign currency forward contracts outstanding as of December 31, 2009, we receive US Dollars in exchange for Canadian Dollars at a weighted average contractual forward foreign currency exchange rate of 1.04 CAD per $1.00 and US Dollars in exchange for Euros at a weighted average contractual foreign currency exchange rate of 0.70 EUR per $1.00.
As of December 31, 2009, the notional value of our outstanding foreign currency forward contracts for our Canadian subsidiary was $15.4 million with contract maturities of 1 month, and the notional value of our outstanding foreign currency forward contracts for our European subsidiary was $56.0 million with contract maturities of 1 month.
The foreign currency forward contracts are not designated as cash flow hedges, and accordingly, changes in their fair value are recorded in other income (expense), net on the consolidated statements of income.
The fair value of our foreign currency forward contracts was $0.3 million and $1.2 million as of December 31, 2009 and 2008, respectively.
These amounts are included in prepaid expenses and other current assets on the consolidated balance sheet.
Refer to Note 9 for a discussion of the fair value measurements.
Other income (expense), net included the following amounts related to changes in foreign currency exchange rates and derivative foreign currency forward contracts:

['

2010
(millions of dollars)	Q1	Q2	Q3	Q4	Full Year
Operating income increase	$4.8	$4.7	$4.6	$4.7	$18.8
Net earnings increase attributable to BorgWarner Inc.	3.7	3.6	3.6	3.6	14.5
Earnings per share increase — Basic	$0.03	$0.03	$0.03	$0.03	$0.13
Earnings per share increase — Diluted	$0.03	$0.03	$0.03	$0.03	$0.11

', '

(millions of dollars)	2010	2009	2008
Year Ended December 31,	U.S.	Non-U.S.	Total	U.S.	Non-U.S.	Total	U.S.	Non-U.S.	Total
Earnings (loss) before taxes	$-26.7	$504.6	$477.9	$-138.5	$156.4	$17.9	$-123.8	$137.8	$14.0
Provision for income taxes:
Current:
Federal/foreign	14.0	117.7	131.7	-2.7	42.7	40.0	7.7	99.5	107.2
State	2.2	—	2.2	1.5	—	1.5	1.0	—	1.0
Total current	16.2	117.7	133.9	-1.2	42.7	41.5	8.7	99.5	108.2
Deferred	-48.9	-3.3	-52.2	-51.6	-8.4	-60.0	-44.7	-30.2	-74.9
Total provision for income taxes	$-32.7	$114.4	$81.7	$-52.8	$34.3	$-18.5	$-36.0	$69.3	$33.3
Effective tax rate	-122.5%	22.7%	17.1%	-38.1%	21.9%	-103.4%	-29.1%	50.3%	237.9%

', '

2011	$128.5
2012	384.1
2013	5.0
2014	0.2
2015	10.0
After 2015	682.4
Total Payments	$1,210.2
Less: Convertible Note Accretion	-25.3
Less: Unamortized Discounts	-4.5
Total	$1,180.4

']

Question: what was the percentage change in the the fair value of our foreign currency forward contracts from 2008 to 2009
Answer: -0.75